期刊文献+

斑贞1号联合氟尿嘧啶对胃癌细胞SGC-7901/ADR的细胞毒作用 被引量:8

Cytotoxicity effect of combination of Banzhen-1 and fluorouracil on multidrug resistance of gastric carcinoma cells SGC-7901/ADR
下载PDF
导出
摘要 目的探讨斑贞1号联合氟尿嘧啶(5-FU)对胃癌SGC-7901/ADR细胞的细胞毒作用。方法以SGC-7901/ADR细胞为靶细胞,分别设5-FU组、斑贞1号组、斑贞1号+5-FU组,采用四甲基偶氮唑盐(MTT)法观察各药物组的细胞毒作用,光镜下动态拍照并用流式细胞仪测定各药物组细胞周期的变化。结果斑贞1号联合5-FU半数抑制浓度(IC50)分别由单独用药时的(7.85±0.03)mg/L(、13.00±0.13)mg/L降至(4.75±0.04)mg/L(P<0.01)。对SGC-7901/ADR细胞毒作用斑贞1号+5-FU>斑贞1号>5-FU。光镜下斑贞1号+5-FU组细胞与单独用药组相比,细胞生长明显受到抑制,癌细胞体积变小,胞体全面皱缩。流式细胞仪检测斑贞1号+5-FU组SGC-7901/ADR细胞明显阻滞在G0/G1期,进入S期细胞减少,抑制癌细胞DNA的合成(P<0.05)。结论斑贞1号联合5-FU较单独用药对SGC-7901/ADR细胞具有明显的细胞毒作用。 Objective To investigate the eytotoxicity effect of combination of Banzhen-1 and fluorouracil(5-FU) on muhidrug resistance of gastric carcinoma cells SGC-7901/ADR. Methods SGC-7901/ADR was considered as target cell and 5-FU, Banzhen-1 and Banzhen-1 + 5-FU were considered as experiment groups. Methyl thiazolyl tetrazolium (MTT) assay was used to investigate half inhibition 50% inhibiting concentration(IC50) of different medicine groups in vitro,which was observed by light microscope. Flow cytometer(FCM) was employed to investigate the cell cycle. Results IC50 of Banzhen-1 and 5-FU were reduced from (7.85±0.03) mg/L and (13.00±0.13) mg/L to (4.75± 0.04) mg/L ( P 〈0.01). The cytotoxieity effect against SGC-7901/ADR cells was Banzhen-1+5-FU〉Banzhen-1〉5- FU. The light microscope revealed that the size of cells exposed to Banzhen-1+ 5-FU became smaller and the cells shrinked than other groups. FCM revealed that cells cycle was stopped at presynthetic phase and ambiguous phase-G0/ G1 phase and the cells that entered the period of DNA synthesis were reduced, so mitosis of cells were inhibited( P 〈 0.05) with the effect of Banzhen-1+5-FU. Conclusion Combination of Banzhen-1 and 5-FU has stronger eytotoxicity effect against SGC-7901/ADR.
出处 《临床荟萃》 CAS 北大核心 2008年第24期1762-1764,共3页 Clinical Focus
关键词 胃肿瘤 细胞系 肿瘤 抗药性 多药 植物制剂 氟尿嘧啶 stomach neoplasms cell line, tumor drug resistance, multiple plant preparations fluorouracil
  • 相关文献

参考文献8

  • 1Lopes EC, Scolnik M, Atvarez E, et al. Modulator activity of PSC833 and cycloporin-A in vincristine and doxorubicin-seleeted multidrug resistant routine leukemic cells[J]. Leuk Res, 2001, 25(1) :85-93.
  • 2Shiraki N, Okamura K, Tokunaga J, et al. Bromocriptine reverses P-glycoprotein-mediated multidrug resistance in tumor or cells[J]. Jpn J Cancer Res,2002,93(2) :209-215.
  • 3Chipponi J, Huguier M, Pezet D, et al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer [J]. Am J Surg,2004,187(3) :440-445.
  • 4司徒镇强.细胞培养[M].北京:世界图书出版社,2000.186.
  • 5Baldini N. Multidrug resistance-a multiplex phenomenon [J]. Nat Med,1997,3(4) :378-380.
  • 6张娟,侯培珍,赵永峰,李翠文,曹瑞珍,王睿琦,高丽君.环孢素A、维拉帕米、川芎嗪对胃癌多药耐药细胞株SGC-7901/ADR逆转作用的研究[J].包头医学院学报,2008,24(3):230-232. 被引量:2
  • 7布立民,孙淑红,韩英.逆转胃肠道肿瘤多药耐药性的研究进展[J].实用癌症杂志,2003,18(1):105-106. 被引量:11
  • 8高学敏.中药学[M].北京:人民卫生出版社,2001.177-1061.

二级参考文献17

  • 1胡艳平,刘健,王庆端,叶启霞,张覃沐.川芎嗪和维拉帕米纠正阿霉素对小鼠艾氏腹水癌的抗药性[J].药学学报,1993,28(1):75-78. 被引量:42
  • 2敖忠芳,夏薇.汉防己甲素逆转白血病细胞耐药的研究[J].中华血液学杂志,1995,16(5):235-237. 被引量:32
  • 3王玉良 巴彦坤.川芎嗪对心血管组织的药理和电生理作用—一种新的钙离子拮抗剂[J].中西医结合杂志,1985,5(5):291-291.
  • 4郭和清,鲁功成,熊旭林,张齐钧,张润清.抗P-糖蛋白单克隆抗体JSB-1和环孢素A协同逆转人膀胱癌MDR的研究[J].中华泌尿外科杂志,1997,18(7):387-390. 被引量:7
  • 5Lopes EC, Scolnik M, Alvarez E, et al. Modulator activity of psc833 and cycloporin -A in cincristine and doxoubic in selected multidrug resistant murine leukemic cells [ J ]. Leu K Res ,2001,25( 1 ) :85 -93.
  • 6Shiraki N, Okamura K, Tokunaga J, et al. Bromocriptine reverses P - glycoprotein - mediated multidrug resistance in tumor or cells [ J ]. Jpn J Cancer Res, 2002,93 : 209 - 215.
  • 7Britton RA, Green JA, Warenius HM. Cellular glutathione (GSH) and glutathione S -transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents[J]. Int J Radiat Oncol Biol Phys,1992,24(3): 527 -531.
  • 8Vassetzky TS, Alghisi GC, Gasser SM, et al. DNA topoisomerase Ⅱ mutation and resistance to anti - tumor drugs [ J ]. Sioessays, 1995,17 (9) :767 - 774.
  • 9Choi JII, Lim IIY, Joo ILJ, et al. Expression of multidrug resistance - associated protein Ⅰ , P - glyeoprotein, and thymidylate synthase in gastric cancer patients treated with 5 - fluorouracil and doxorubicin -based adjuvant chemotherapy after curative resection [ J ]. Br J Cancer, 2002,86 ( 10 ) : 1578 - 1585.
  • 10Scheithauer W, Schenk T, Czejka M. Pharmacodinetic interation between pirubicin and the multidrug resistance recerting agent D - veraamil [ J ]. Br J Cancer, 1993,68 ( 1 ) : 8 - 9.

共引文献112

同被引文献35

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部